Measuring Quality in Colorectal Cancer Surgery in Low- and Middle-income Countries
- Conditions
- Non-communicable DiseaseColorectal CancerPostoperative ComplicationsSurgical Complication
- Registration Number
- NCT05182762
- Lead Sponsor
- Sahlgrenska University Hospital, Sweden
- Brief Summary
To test the applicability of the Clavien-Dindo Classification (CDC) in an LMIC setting and to compare the prevalence and severity of complications in patients \<60 and β₯60 years of age a retrospective medical records review is used.
- Detailed Description
Background: Colorectal cancer (CRC) is increasing in Low- and Middle-Income Countries (LMIC) as part of the ongoing epidemiological transition. Surgery is the main treatment and the global health agenda is increasingly putting focus on improving the safety and quality of surgical care in low-resource settings. The current systems for measuring surgical quality are mainly customized for high-income countries.
Aim: To test the applicability of the Clavien-Dindo Classification (CDC) in an LMIC setting. Additionally, to compare the prevalence and severity of complications in patients \<60 and β₯60 years of age.
Material and methods: Retrospective medical records review for postoperative complications and severity grading using the CDC.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- Patients who has gone through colorectal cancer resection.
- Surgery performed at Colombo South Teaching Hospital in Colombo, Sri Lanka.
- Reason for resection other than colorectal cancer.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clavien-Dindo Grade February 2020 to March 2020 Postoperative complications graded by the Clavien-Dindo Classification.
- Secondary Outcome Measures
Name Time Method Age comparison February 2020 to March 2020 Comparison of prevalence and severity of complications between patients \<60 and β₯60 years of age.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University of Gothenburg, Sahlgrenska Academy
πΈπͺGothenburg, Sweden